Grantham, Mayo, Van Otterloo & Co (GMO)’s Community Health Systems CYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-10,500
Closed -$46.2K – 598
2023
Q2
$46.2K Sell
10,500
-9,900
-49% -$42.1K ﹤0.01% 671
2023
Q1
$100K Buy
+20,400
New +$107K ﹤0.01% 677
2022
Q4
– Sell
-50,400
Closed -$108K – 727
2022
Q3
$108K Buy
+50,400
New +$167K ﹤0.01% 698
2021
Q1
– Sell
-23,000
Closed -$171K – 862
2020
Q4
$171K Buy
+23,000
New +$163K ﹤0.01% 784
2018
Q1
– Sell
-66,300
Closed -$282K – 585
2017
Q4
$282K Buy
66,300
+25,100
+61% +$126K ﹤0.01% 525
2017
Q3
$316K Buy
+41,200
New +$321K ﹤0.01% 467
2016
Q3
– Sell
-600,000
Closed -$7.23M – 535
2016
Q2
$7.23M Buy
+600,000
New +$8.79M 0.03% 262
2013
Q4
– Sell
-67,084
Closed -$2.3M – 673
2013
Q3
$2.3M Sell
67,084
-11,950
-15% -$424K 0.01% 393
2013
Q2
$3.06M Buy
+79,034
New +$2.98M 0.01% 361

Other funds holding CYH

Grantham, Mayo, Van Otterloo & Co (GMO)'s CYH Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Community Health Systems (CYH) in Q3 2023, closing a stake of 10,500 shares — an estimated $46.2K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CYH in Q2 2013 and held it in 9 quarters. The position peaked at $7.23M in Q2 2016. 186 funds tracked by Wall St. Rank hold CYH as of Q3 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Community Health Systems position as of Q3 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,500 Community Health Systems shares in Q3 2023, an estimated $46.2K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Community Health Systems in Q2 2013 and held it in 9 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Community Health Systems position peaked at $7.23M in Q2 2016.
  • 186 funds tracked by Wall St. Rank held Community Health Systems as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.